Published in Vestn Khir Im I I Grek on September 01, 1989
[Smoking: the main cause of high mortality rate among Russian population]. Vestn Ross Akad Med Nauk (2002) 0.77
Direct antiviral effect of cycloferon (10-carboxymethyl-9-acridanone) against adenovirus type 6 in vitro. Antiviral Res (2003) 0.77
[The therapeutic efficacy of cycloferon and the pharmacological activity of interferon inducers]. Ter Arkh (2014) 0.75
[Protective effect of cycloferon in experimental influenza]. Vopr Virusol (2001) 0.75
[INFLUENCE OF ANGIOPROTECTOR DRUGS ON THE EFFICACY OF CYTOSTATIC THERAPY (EXPERIMENTAL STUDY)]. Eksp Klin Farmakol (2016) 0.75
[Cycloferon efficacy of therapy of chronic hepatitis B (results of randomized multicentre study)]. Antibiot Khimioter (2010) 0.75
[Rationale of application of the drug Cytoflavin in complex treatment of patients with diabetic foot syndrome with mediacalcification arteries]. Khirurgiia (Mosk) (2014) 0.75
[Cycloferon in emergency prophylaxis of respiratory viral infections and influenza]. Klin Med (Mosk) (2011) 0.75
[Interferon inductor activity and interferon production under the action of acridonacetic acid salts]. Eksp Klin Farmakol (2014) 0.75
[Induction of type 1, 2 and 3 interferons by acridone acetates]. Antibiot Khimioter (2014) 0.75
[Effectiveness of cycloferon in treating virus-associated inflammatory gynecologic diseases]. Vopr Virusol (1999) 0.75
[Use of cytoflavin for correction of complications of myocardial infarction]. Eksp Klin Farmakol (2002) 0.75
[Cycloferon efficacy in viral and bacterial diseases of children (clinical review)]. Antibiot Khimioter (2010) 0.75
[Pathogenetic correction of metabolic disturbances in chronic liver affections]. Antibiot Khimioter (2012) 0.75
[Cycloferon in therapy of hyperplastic laryngitis for decrease of the number of relapses]. Eksp Klin Farmakol (2013) 0.75
[Effect of cycloferon on dissemination of Lewis lung carcinoma in mice and rhabdomyosarcoma ra-23 in rats]. Vopr Onkol (1999) 0.75
[Experimental study of cytoprotector effect of succinate-containing drugs on functional activity of liver]. Eksp Klin Farmakol (2010) 0.75
[Pathogenetic therapy of tuberculosis of respiratory organs during sanatorium-and-spa treatment]. Vopr Kurortol Fizioter Lech Fiz Kult (2009) 0.75
[Problems in treating influenza and acute respiratory infection in children]. Eksp Klin Farmakol (2011) 0.75
[Efficacy of antioxidant energocorreсtion in brain infarction (results of a multicenter randomized trial)]. Zh Nevrol Psikhiatr Im S S Korsakova (2014) 0.75
[Effect of succinate- and methionine-containing drug runihol on reparative regeneration processes in liver under experimental hepatectomy conditions]. Eksp Klin Farmakol (2012) 0.75
[A rare complication of hepatic echinococcosis]. Med Parazitol (Mosk) (1985) 0.75
[Comparative diagnostic value of roentgenofunctional and spirographic indicators]. Sov Med (1981) 0.75
Effects of cytoflavin and neuronol on morphological changes in the brain and survival of rats with ischemic disturbances in cerebral blood flow. Bull Exp Biol Med (2004) 0.75
[Effect of cycloferon on the evolution of cervical and vaginal cancer in mice]. Vopr Onkol (2000) 0.75
[The Janus syndrome observed during mass fluorographic screening of the population]. Vestn Rentgenol Radiol (1991) 0.75
[Modern methods of energy homeostasis correction in elderly patients]. Adv Gerontol (2014) 0.75
[The teaching of oncology in college--today's requirements]. Vopr Onkol (1989) 0.75
[Gerontological trends of contemporary forms of alcohol dependence. Approaches to full compensation and rehabilitation]. Adv Gerontol (2014) 0.75
[Experimental and clinicolaboratory evaluation of complex therapy efficacy in arboviral infections]. Antibiot Khimioter (2012) 0.75
[Cycloferon as an agent for the anti-relapse therapy in patients with chronic hyperplastic sinusitis]. Antibiot Khimioter (2013) 0.75
[Correction of postischemic reperfusion injury complications by cytoflavin]. Biull Eksp Biol Med (2000) 0.75
Neuroprotective effect of cytoflavin during compression injury of the spinal cord. Bull Exp Biol Med (2005) 0.75
[The hepatotropic activity of runihol and ademethionine against experimental liver damage caused by first-line antituberculosis drugs]. Arkh Patol (2014) 0.75
[Efficacy of cytoflavin in the treatment of chronic cerebral ischemia]. Klin Med (Mosk) (2010) 0.75
[Immunotropic and antihypoxant therapy of experimental drug-sensitive and drug-resistant tuberculosis]. Patol Fiziol Eksp Ter (2013) 0.75
[Effect of hepatoprotector remaxol infusion on liver function in obstructive jaundice model in rats]. Eksp Klin Farmakol (2010) 0.75
[Transcutaneous cholangiography and cholangitis]. Klin Med (Mosk) (1967) 0.75
[Postgraduate training of pharmacists at the Kiev Institute of Physician Postgraduate Training]. Farm Zh (1973) 0.75
[Detoxicating properties of remaxol with respect to multiple organ failure during severe ethanol poisoning]. Eksp Klin Farmakol (2010) 0.75
[Surgical treatment of hepatic alveococcosis with metastases to the lungs and brain]. Khirurgiia (Mosk) (1986) 0.75
[Effect of infusion hepatoprotectors on hepatic function in experimental cholestasis]. Khirurgiia (Mosk) (2010) 0.75
[Cycloferon, as an agent in the therapy and urgent prophylaxis of influenza and acute respiratory tract viral infection (multicentre randomized controlled comparative study)]. Antibiot Khimioter (2009) 0.75
[Comparative evaluation of reamberin and mafusol on acute toxic liver damage models]. Eksp Klin Farmakol (2012) 0.75
[Immunomodulator Cycloferon in the comprehensive treatment of patients with acute non-lymphoblastic leukemia]. Vopr Onkol (1999) 0.75
[Comparative study of hepatoprotective action of remaxol, reamberin and ademethionine in liver injury induced by antituberculosis drugs (experimental study)]. Antibiot Khimioter (2011) 0.75
[Efficacy of antiviral agents in the treatment of Crimean hemorrhagic fever]. Klin Med (Mosk) (2012) 0.75
[Peritonitis after operations in hepatic alveolar hydatid disease]. Vestn Khir Im I I Grek (1984) 0.75
[Therapeutic efficiency of cytoflavine solution for infusion in emergency conditions]. Klin Med (Mosk) (2010) 0.75
[Latent encephalopathy in alveococcosis complicated by cholestasis]. Sov Med (1986) 0.75
[Efficiency of using cycloferon as part of combined therapy for chronic hepatitis C (a review of multicenter clinical trials)]. Ter Arkh (2010) 0.75
[Improvement of natural resistance in children for prophylaxis of influenza and acute respiratory tract viral infections (results of multicenter randomized trials)]. Antibiot Khimioter (2009) 0.75
[Modified therapy of herpetic infection]. Klin Med (Mosk) (2011) 0.75
[Morpho-functional changes in the kidneys in patients with hepatic alveococcosis]. Klin Med (Mosk) (1986) 0.75
[The problem of instability of perception and interpretation of x-ray images of spheroidal lung formations]. Vestn Rentgenol Radiol (1989) 0.75
[Intrahepatic induction of endogenous S-adenosyl-L-methionine against the background of various ways of administration of methionine-succinate complex and its role in drug-induced liver lesion correction]. Vestn Ross Akad Med Nauk (2012) 0.75
[Combined cycloferon treatment of tuberculosis in patients infected with HIV]. Eksp Klin Farmakol (2010) 0.75
[Virus infections and interferon inducers in the complex therapy]. Antibiot Khimioter (2013) 0.75
[Neuroprotective effect of cytoflavin in closed craniocerebral trauma]. Eksp Klin Farmakol (2004) 0.75
[Free-radical oxidation and antioxidant protection by experimental cholestasis]. Khirurgiia (Mosk) (2011) 0.75
[The use of cycloferon in the therapy of experimental herpetic keratitis]. Antibiot Khimioter (2000) 0.75
[Preclinical study of Reamberin and Remaxol safety]. Eksp Klin Farmakol (2010) 0.75
Inhibitory effect of synthetic interferon inductor Cycloferone on 1,2-dimethylhydrazine-induced colon carcinogenesis in rats. Cancer Lett (2000) 0.75
[Cycloferon--a new domestic preparation for the prophylaxis of influenza and other acute respiratory viral infections]. Zh Mikrobiol Epidemiol Immunobiol (2005) 0.75
[Study of detoxifying efficacy of remaxol in experimental model of cisplatin-induced toxicosis]. Eksp Klin Farmakol (2011) 0.75
[Fluorography method of studying external respiration]. Vestn Rentgenol Radiol (1986) 0.75
[Immunomodulators in combined therapy of patients with chronic hepatitis]. Antibiot Khimioter (2011) 0.75
[Analysis of mortality after surgery for alveococcosis of the liver]. Vestn Khir Im I I Grek (1982) 0.75
[The effect of cycloferon administration on the growth of transplantable tumors in rats and mice]. Vopr Onkol (1998) 0.75
[The complex energy correction of chronic brain ischemia]. Zh Nevrol Psikhiatr Im S S Korsakova (2011) 0.75
[Surgical treatment of bilateral forms of pulmonary tuberculosis]. Probl Tuberk (2002) 0.75
[Comparative study of remaxol and ademethionine effects on reparative regeneration processes in the liver subjected to surgical intervention]. Eksp Klin Farmakol (2011) 0.75
[Evaluation of safety and pharmacotherapeutic efficacy of cycloferon in treatment of Astrakhan rickettsial fever]. Antibiot Khimioter (2012) 0.75
[Postoperative complications in hepatic alveococcosis]. Khirurgiia (Mosk) (1986) 0.75
[Rational pharmacotherapy and correction of immunity disorders in children with chronic hepatitis (clinical review)]. Antibiot Khimioter (2010) 0.75
[Reamberin for pathogenetic therapy of acute and chronic viral diseases of the liver]. Klin Med (Mosk) (2010) 0.75
[Cycloferon in treating duodenal ulcers in rats]. Eksp Klin Farmakol (2002) 0.75
[Up-to-date approach to treatment of inflammatory infections in the maxillofacial region]. Antibiot Khimioter (2009) 0.75
[Efficacy of cytoflavin in therapy of encephalophathy in patients with neuroinfection]. Antibiot Khimioter (2010) 0.75
[Supply of teaching materials and manikins to medical schools]. Klin Med (Mosk) (1991) 0.75
[Correction of free radical processes by a succinic acid drug (reamberine) in intensive care of patients with acute neurotropic poisoning]. Anesteziol Reanimatol (2001) 0.75
[Cycloferon in the treatment of infectious diseases]. Antibiot Khimioter (2008) 0.75
[Correction of adverse reactions in antimicrobial therapy of respiratory tract tuberculosis]. Antibiot Khimioter (2008) 0.75
[Possibilities for the correction of immune disorders during tuberculosis infection]. Klin Med (Mosk) (2010) 0.75
[Dose-dependent interferon-induction activity and pharmacokinetics of cycloferon in healthy humans]. Eksp Klin Farmakol (2012) 0.75
[Pathogenetically substantiated therapy of patients with virus hepatitis C, quality of life, and the disease outcome risk (clinical survey)]. Antibiot Khimioter (2010) 0.75
[Effect of antiviral drugs with various mechanisms of action on morphogenesis of infection caused by extremely pathogenic influenza virus strains in animals]. Eksp Klin Farmakol (2011) 0.75
Experimental study of biological activity of angiogen in experimental cardiovascular and hemostasis pathology. Bull Exp Biol Med (2002) 0.75
[Antiamnesic effect of cytoflavin and neuronol in rats with ischemic impairment of cerebral circulation]. Eksp Klin Farmakol (2004) 0.75
[Chemotherapy of chronic viral hepatitis B: randomized multicenter investigation results]. Eksp Klin Farmakol (2010) 0.75
[Remaxol restores the liver antioxidant protection system in experimental cyclophosphan-induced injury]. Eksp Klin Farmakol (2011) 0.75
[X-ray diagnosis of chronic bronchitis]. Klin Med (Mosk) (1979) 0.75
[Prevention of cognitive dysfunction in patients operated on thyroid gland]. Khirurgiia (Mosk) (2011) 0.75
[Experimental study of remaxol as a drug for supportive therapy in traditional and high-dose treatment of tumors]. Eksp Klin Farmakol (2013) 0.75
[Dynamics of arterial pressure, pressor and metabolic reactions to norepinephrine in the process of adaptation of animals to cold]. Kardiologiia (1971) 0.75
[Induction of endogenous s-adenosyl-l-methionine in hepatocytes during pharmacological correction of experimental acute toxic and chronic drug-induced liver injury]. Eksp Klin Farmakol (2011) 0.75
Effect of neuronol on lifespan and development of spontaneous tumors in SAMP-1 mice with genetically accelerated aging. Bull Exp Biol Med (2003) 0.75
[The use of cycloferon in experimental radiotherapy of tumors]. Vopr Onkol (1999) 0.75
[Cycloferon in complex therapy management of chronic laryngitis]. Antibiot Khimioter (2013) 0.75